Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-05-24
2011-05-24
Skelding, Zachary (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S040500
Reexamination Certificate
active
07947464
ABSTRACT:
The present invention relates to methods and kits for identifying, quantifying and isolating regulatory T cells, to methods and kits for diagnosing or monitoring autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer, cancer treatment and/or organ transplantation based on regulatory T cell quantity, to methods and kits for predicting responses to therapy for autoimmune diseases, immunoinflammatory diseases, allergic diseases, predispositions thereto, infectious diseases, cancer and/or organ transplantation based on regulatory T cell quantity, and to methods and kits for therapy using isolated regulatory T cells.
REFERENCES:
Baecher-Allan et al., Semin Immunol. Apr. 2004;16(2):89-98.
Paiardini, M., et al., “Loss of CD127 Expression Defines an Expansion of Effector CD8+T Cells in HIV-Infected Individuals,” The Journal Of Immunology, 2005, pp. 2900-2909, 0022-1767/05, The American Association of Immunologists, Inc.
Caton, A. J., et al., “CD4+CD25+Regulatory T Cell Selection,” Annals New York Academy of Sciences, 2004, pp. 101-114, vol. 1029, New York Academy of Sciences.
Seddiki, N., et al., “Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells,” JEM, Jul. 10, 2006, pp. 1693-1700, vol. 203, No. 7, The Rockefeller University Press, www.jem.org/cgi/doi/10.1084/jem.20060468.
Cozzo, C., et al., “Cutting Edge: Self-Peptides Drive the Peripheral Expansion of CD4+CD25+Regulatory T Cells”, Track Proliferation in GFP+Cells! Cell Proliferation Dye eFluor® 670, The Journal of Immunology, 2003, pp. 5678-5682, 171, The American Association of Immunologists, Inc.
Alpdogan, O., et al., “IL-7 Administration Enhances Peripheral T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) through Increased Homeostatic Profileration and Anti-Apoptotic Effects”, Experimental Transplantation I: Immune Reconstitution, Stem Cells and Mobilization, p. 107a, 2003.
Seddiki, N., et al., “A New Gating Strategy to Identify Human Regulatory T Cells”, Tissue Antigens, Nov. 2005, p. 537, vol. 66 No. 5, Blackwell Munksgaard.
L.S. Ou et al., “T regulatory cells in atopic dermatitis and subversion of their activity by superantigens,” J Allergy Clin Immunol, vol. 113, No. 4, Apr. 2004.
C. Karagiannidis et al., “Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma,” J Allergy Clin Immunol, vol. 114, No. 6, Dec. 2004.
CD4 CD25highregulatory T cells are not impaired in patients with primary Sjogren's syndrome, Journal of Autoimmunity 24 (2005) 235-242.
K. Wood et al., “Regulatory T Cells in Transplantation Tolerance,” Nature Reviews, Immunology; vol. 3, Mar. 2003.
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications, Immunology Letters 94 (2004) 11-26.
T. Cupedo et al., “Development and activation of regulatory T cells in the human fetus,” Eur. J. Immunol. 2005. 35: 383-390.
N.E. Aerts et al., “Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis,” Cellular Immunology 251 (2008) 109-115.
W. Liu et al., “CD127 expression inversely correlates with Fox P3 and suppressive function of human CD4+T reg calls,” The Journal of Experimental Medicine, vol. 203, No. 7, Jul. 10, 2006, 1701-1711.
CD25+CD4+Regulatory Cells in Patients with Kawasaki Disease, The Journal of Pediatrics, Sep. 2004.
A. Kukreja et al.,“Multiple immuno-regulatory defects in type-1 diabetes,” The Journal of Clinical Investigation, Jan. 2002, vol. 109, No. 1.
D. Cao et al., “Isolation and functional characteristics of regulatory CD25brightCD4+T cells from the target organ of patients with rheumatoid arthritis,” Eur. J. Immunol. 2003. 33:215-223.
J.C. Crispin et al., “Quantification of regulatory T cells in patients with systemic lupus erythematosus,” Journal of Autoimmunity 21 (2003) 273-276.
CD25+CD4+Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+and CD8+HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status, The Journal of Experimental Medicine, vol. 200, No. 3, Aug. 2, 2004, 331-343.
J. Maul et al., “Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease,” Gastroenterology 2005; 128; 1868-1878.
L.A. Ormandy et al., “Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma,” Cencer Res 2005; 65: (6). Mar. 15, 2005.
Fazekas De St Groth Barbara Denise
Kelleher Anthony Dominic
Landay Alan Lee
Sasson Sarah Christina
Seddiki Nabila
Centenary Institute of Cancer Medicine and Cell Biology
McDermott Will & Emery LLP
Skelding Zachary
LandOfFree
Method for identifying regulatory T cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying regulatory T cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying regulatory T cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695091